# Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Refractory Focal Epilepsy

> **NCT05886205** · EARLY_PHASE1 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 34 (estimated)

## Conditions studied

- Refractory Focal Epilepsy

## Interventions

- **DRUG:** iPSC-Exos

## Key facts

- **NCT ID:** NCT05886205
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-05
- **Primary completion:** 2025-06-13
- **Final completion:** 2025-11-13
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2023-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05886205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05886205, "Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Refractory Focal Epilepsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05886205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*